Investigating the Consistancy Rate of Hypertension Treatment through Guide Line JNC-7, in Patients Who Were Referred to Health Centers and Health Houses of Fasa University of Medical Sciences 2012

Message:
Abstract:
Background and Objective
Choosing antihypertensive as a drug for treating hypertension is the most important part of its treatment. The present study was done in investigating the consistancy rate of hypertension treatment through Guide Line JNC-7 in patients who were referred to health centers and health houses of Fasa University of Medical Sciences in 2012.
Materials and Methods
In this cross- sectional study, the non-random sample of population was consisted of 200 patients who were suffering from hypertension. The questionnaire contained both demographic information and the use of anti-hypertension medication based on guide line (JNC-7 (. After the confirmation approval of content validity and reliability of the questionnaire, the data and the descriptive statistics were analyzed through SPSS-15 software.
Results
60 ٪ of the patients were in the first stage of hypertension and 40 percent of them were in the second one. Beta blockers were the most common prescribed drugs which were used among the first stage patients. However, ACEI and Diuretics (Thiazides) were the commonly prescribed drugs for the second stage hypertension patients. Patients who had diabetes and heart failure were used Beta- blocker drugs which was not in line with the Guide line JNC-7.
Conclusions
The treatment of hypertension in patients was not in consistence with guideline JNC-7. It is recommended to organize training classes for doctors to inform patients about the better way of treating this problem.
Language:
Persian
Published:
Journal of Advanced Biomedical Sciences, Volume:4 Issue: 1, 2014
Pages:
74 to 80
magiran.com/p1282548  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!